Enzyme News and Research

RSS
Ebola research: an interview with Professor Easton, University of Warwick

Ebola research: an interview with Professor Easton, University of Warwick

Biologists show bioelectrical signals control tumors arising from cancer-causing genes, fatty acid

Biologists show bioelectrical signals control tumors arising from cancer-causing genes, fatty acid

Genetically modified swine skin grafts may provide new treatment for burn injuries

Genetically modified swine skin grafts may provide new treatment for burn injuries

Researchers develop active agents that may improve healing of inflammatory illnesses

Researchers develop active agents that may improve healing of inflammatory illnesses

Researchers discover novel enzyme that promotes insulin secretion in type 2 diabetes animal model

Researchers discover novel enzyme that promotes insulin secretion in type 2 diabetes animal model

Scientists develop 3-D artificial enzyme cascade that mimics biochemical pathway using DNA molecules

Scientists develop 3-D artificial enzyme cascade that mimics biochemical pathway using DNA molecules

Researchers discover signaling pathway in cancer cells that invades nearby tissues

Researchers discover signaling pathway in cancer cells that invades nearby tissues

Researchers discover how gene commonly linked to obesity contributes to weight gain

Researchers discover how gene commonly linked to obesity contributes to weight gain

Researchers identify mutation in fat-storage gene that appears to increase risk for type 2 diabetes

Researchers identify mutation in fat-storage gene that appears to increase risk for type 2 diabetes

Researchers resolve long-standing mystery of enzyme's role in cell survival

Researchers resolve long-standing mystery of enzyme's role in cell survival

New discovery cracks code of metabolic pathway that allows certain cancerous tumors to thrive

New discovery cracks code of metabolic pathway that allows certain cancerous tumors to thrive

NCCN receives $2M grant to evaluate effectiveness of volasertib in treatment of hematologic malignancies

NCCN receives $2M grant to evaluate effectiveness of volasertib in treatment of hematologic malignancies

TUSM scientists receive $11.5M grant to develop innovative treatments for heart failure

TUSM scientists receive $11.5M grant to develop innovative treatments for heart failure

UNC researchers find new enzyme target for treating chronic pain

UNC researchers find new enzyme target for treating chronic pain

Researchers identify existing drugs that could be "repurposed" to fight MERS-CoV

Researchers identify existing drugs that could be "repurposed" to fight MERS-CoV

New "18F radiotracers" to detect and track certain diseases in patients

New "18F radiotracers" to detect and track certain diseases in patients

New laser method provides a better understanding on how genes are controlled, regulated

New laser method provides a better understanding on how genes are controlled, regulated

Mayo Clinic study provides key insights into aggressive form of pancreatic cancer

Mayo Clinic study provides key insights into aggressive form of pancreatic cancer

Research provides key insights into most aggressive form of pancreatic cancer

Research provides key insights into most aggressive form of pancreatic cancer

Sanofi presents Phase II trial results for investigational vaccine for prevention of CDI

Sanofi presents Phase II trial results for investigational vaccine for prevention of CDI

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.